Cronos Group Inc.CRON

NasdaqHealthcareMedicinal Chemicals & Botanical Products
Price (close)
$3.34
Market cap
$1.2B
P/E
17.6x
Revenue (TTM)
$179.1M
Net income
$70.0M
Dividend yield
—
1-year total return
26.5%
Net margin
39.1%
Revenue growth
37.5%
Debt / equity
—

What Cronos Group Inc. does.

Cronos is incorporated under the laws of the Province of British Columbia with principal executive offices located at 4491 Concession Rd 12, Stayner, Ontario L0M 1S0. The Company’s telephone number is +1-416-504-0004, the website is https://thecronosgroup.com/ and the investor relations section of the website is https://ir.thecronosgroup.com/. All references to Cronos’ website are inactive references, are for informational purposes only and are not intended to incorporate any information from or referenced on its website into this Annual Report.

Cronos common shares are currently listed on the Toronto Stock Exchange (“TSX”) and on the NASDAQ Global Market (“Nasdaq”) under the trading symbol “CRON.”

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach ® , PEACE NATURALS ® , LIT™, and Lord Jones ® .

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$46.7M$64.6M$86.7M$87.2M$117.6M$146.6M
Net income-$73.1M-$396.1M-$168.7M-$74.0M$41.1M-$9.4M
Free cash flow-$176.3M-$164.8M-$92.4M-$45.3M$6.4M$149,000

More on CRON.

Figures from Cronos Group Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.